Clinical trials
Headache trials in Denmark
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
63 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 4 |
| 2007 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 7 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 8 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 43 |
| Unknown status | 8 |
| Terminated | 3 |
| Recruiting | 3 |
| Not yet recruiting | 3 |
| Active, not recruiting | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Danish Headache Center | 39 |
| Eli Lilly and Company | 4 |
| Amgen | 3 |
| University of Aarhus | 3 |
| Pfizer | 2 |
| University Hospital Bispebjerg and Frederiksberg | 2 |
| Boston Scientific Corporation | 1 |
| Glostrup University Hospital, Copenhagen | 1 |
| H. Lundbeck A/S | 1 |
| Janssen Pharmaceutica N.V., Belgium | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Headache | 63 |
| Migraine Disorders | 31 |
| Pain | 10 |
| Headache Disorders | 6 |
| Migraine without Aura | 5 |
| Epilepsy | 4 |
| Migraine with Aura | 4 |
| Headache Disorders, Primary | 3 |
| Neurologic Manifestations | 3 |
| Post-Traumatic Headache | 3 |
Trials
Showing 51 to 63 of 63. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.